Montana's SB422 'Right to Try' bill allows access to experimental treatments, expanding medical autonomy and setting a precedent for healthcare innovation.
Mitchell Lee, CEO of Ora Biomedical, is revolutionizing longevity research with high-throughput screening in C. elegans, aiming to screen over 1 million compounds in